 Suet Nee Chen
Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arrhythmogenic Right Ventricular Dysplasia | 2 | 2017 | 35 | 1.020 |
Why?
| | Cardiomyopathy, Hypertrophic | 9 | 2012 | 122 | 0.910 |
Why?
| | Cardiomyopathies | 4 | 2018 | 303 | 0.800 |
Why?
| | Myocytes, Cardiac | 7 | 2019 | 457 | 0.800 |
Why?
| | Lamin Type A | 2 | 2019 | 40 | 0.800 |
Why?
| | Coronary Artery Disease | 4 | 2009 | 607 | 0.750 |
Why?
| | Cardiomyopathy, Dilated | 2 | 2019 | 352 | 0.650 |
Why?
| | DNA Damage | 1 | 2019 | 357 | 0.550 |
Why?
| | Muscle Proteins | 3 | 2012 | 209 | 0.520 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2018 | 183 | 0.520 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2019 | 449 | 0.500 |
Why?
| | Adipogenesis | 1 | 2013 | 42 | 0.440 |
Why?
| | Mutation, Missense | 2 | 2012 | 296 | 0.420 |
Why?
| | Gene Deletion | 2 | 2016 | 355 | 0.400 |
Why?
| | Mutation | 4 | 2019 | 3364 | 0.390 |
Why?
| | Cholesterol, HDL | 2 | 2009 | 185 | 0.380 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2012 | 139 | 0.380 |
Why?
| | Genetic Association Studies | 1 | 2009 | 345 | 0.300 |
Why?
| | Myocardium | 4 | 2019 | 926 | 0.290 |
Why?
| | Haplotypes | 3 | 2007 | 457 | 0.290 |
Why?
| | Arrhythmias, Cardiac | 2 | 2018 | 279 | 0.250 |
Why?
| | Hyperlipoproteinemia Type II | 1 | 2005 | 26 | 0.250 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2009 | 1919 | 0.250 |
Why?
| | Serine Endopeptidases | 1 | 2005 | 102 | 0.240 |
Why?
| | Genetic Markers | 1 | 2005 | 325 | 0.230 |
Why?
| | Hypolipidemic Agents | 1 | 2004 | 87 | 0.220 |
Why?
| | Genetic Predisposition to Disease | 3 | 2018 | 2129 | 0.220 |
Why?
| | Fibrosis | 5 | 2019 | 457 | 0.200 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 195 | 0.200 |
Why?
| | Genotype | 4 | 2009 | 1787 | 0.200 |
Why?
| | Calcineurin | 2 | 2012 | 84 | 0.200 |
Why?
| | Desmosomes | 2 | 2017 | 20 | 0.180 |
Why?
| | Genetic Variation | 1 | 2005 | 880 | 0.170 |
Why?
| | Lipids | 1 | 2004 | 588 | 0.170 |
Why?
| | E2F Transcription Factors | 1 | 2019 | 55 | 0.160 |
Why?
| | Mice | 7 | 2019 | 15052 | 0.150 |
Why?
| | Gene Frequency | 3 | 2009 | 485 | 0.150 |
Why?
| | Muscular Dystrophies | 1 | 2018 | 36 | 0.150 |
Why?
| | Myocardial Contraction | 2 | 2018 | 315 | 0.150 |
Why?
| | Ion Channels | 1 | 2018 | 123 | 0.150 |
Why?
| | Carrier Proteins | 3 | 2012 | 701 | 0.140 |
Why?
| | Fatty Acids, Monounsaturated | 2 | 2009 | 47 | 0.140 |
Why?
| | Acetylcysteine | 2 | 2009 | 144 | 0.140 |
Why?
| | Desmoplakins | 1 | 2016 | 19 | 0.130 |
Why?
| | Linkage Disequilibrium | 2 | 2009 | 247 | 0.130 |
Why?
| | Transcription Factors | 1 | 2004 | 1528 | 0.130 |
Why?
| | Animals | 11 | 2019 | 32104 | 0.130 |
Why?
| | Signal Transduction | 4 | 2019 | 4541 | 0.120 |
Why?
| | Indoles | 2 | 2009 | 309 | 0.120 |
Why?
| | Adipocytes | 1 | 2016 | 188 | 0.120 |
Why?
| | Antioxidants | 2 | 2009 | 533 | 0.110 |
Why?
| | Mice, Transgenic | 4 | 2012 | 1970 | 0.110 |
Why?
| | Genomics | 1 | 2017 | 646 | 0.110 |
Why?
| | Tripartite Motif Proteins | 1 | 2012 | 29 | 0.100 |
Why?
| | Humans | 15 | 2018 | 115741 | 0.100 |
Why?
| | Triglycerides | 2 | 2005 | 473 | 0.100 |
Why?
| | Sarcomeres | 1 | 2012 | 89 | 0.100 |
Why?
| | Cell Proliferation | 1 | 2019 | 2194 | 0.100 |
Why?
| | Male | 10 | 2019 | 56050 | 0.100 |
Why?
| | Stem Cells | 1 | 2016 | 546 | 0.100 |
Why?
| | Fibroblasts | 1 | 2016 | 839 | 0.100 |
Why?
| | Apoptosis | 2 | 2019 | 2377 | 0.090 |
Why?
| | Female | 10 | 2019 | 60018 | 0.090 |
Why?
| | Amino Acid Sequence | 2 | 2012 | 2000 | 0.090 |
Why?
| | Models, Animal | 1 | 2012 | 350 | 0.090 |
Why?
| | Mice, Knockout | 2 | 2013 | 2604 | 0.090 |
Why?
| | Molecular Sequence Data | 2 | 2012 | 2790 | 0.090 |
Why?
| | Apolipoprotein A-I | 1 | 2009 | 25 | 0.090 |
Why?
| | Myosin Heavy Chains | 3 | 2009 | 169 | 0.090 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2012 | 362 | 0.080 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2009 | 43 | 0.080 |
Why?
| | Heart Failure, Systolic | 1 | 2009 | 20 | 0.080 |
Why?
| | Cell Differentiation | 1 | 2016 | 1700 | 0.080 |
Why?
| | Genes, Dominant | 2 | 2007 | 93 | 0.080 |
Why?
| | Cell Line | 1 | 2013 | 2651 | 0.080 |
Why?
| | Phenotype | 6 | 2018 | 2839 | 0.070 |
Why?
| | DNA Mutational Analysis | 2 | 2007 | 372 | 0.070 |
Why?
| | Sulfhydryl Compounds | 1 | 2009 | 178 | 0.070 |
Why?
| | Alleles | 1 | 2009 | 794 | 0.070 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 3 | 2018 | 263 | 0.070 |
Why?
| | Cholesterol | 2 | 2005 | 369 | 0.070 |
Why?
| | Aged | 4 | 2009 | 19294 | 0.070 |
Why?
| | Chromosome Mapping | 1 | 2007 | 489 | 0.070 |
Why?
| | Cells, Cultured | 4 | 2018 | 3914 | 0.070 |
Why?
| | Middle Aged | 5 | 2009 | 27069 | 0.060 |
Why?
| | Quantitative Trait Loci | 1 | 2007 | 313 | 0.060 |
Why?
| | Heptanoic Acids | 1 | 2005 | 60 | 0.060 |
Why?
| | Proprotein Convertases | 1 | 2005 | 14 | 0.060 |
Why?
| | Case-Control Studies | 1 | 2012 | 3037 | 0.060 |
Why?
| | Disease Models, Animal | 4 | 2012 | 3580 | 0.060 |
Why?
| | Proprotein Convertase 9 | 1 | 2005 | 61 | 0.060 |
Why?
| | Lipoprotein(a) | 1 | 2005 | 51 | 0.060 |
Why?
| | Fluorescent Antibody Technique | 2 | 2018 | 398 | 0.060 |
Why?
| | Chromosome Aberrations | 1 | 2005 | 134 | 0.060 |
Why?
| | Pyrroles | 1 | 2005 | 185 | 0.060 |
Why?
| | Multifactorial Inheritance | 1 | 2005 | 125 | 0.060 |
Why?
| | Aldosterone | 1 | 2004 | 42 | 0.060 |
Why?
| | Pharmacogenetics | 1 | 2005 | 151 | 0.060 |
Why?
| | Transgenes | 1 | 2004 | 169 | 0.060 |
Why?
| | Anticholesteremic Agents | 1 | 2005 | 129 | 0.050 |
Why?
| | Genome-Wide Association Study | 1 | 2009 | 1218 | 0.050 |
Why?
| | Body Mass Index | 1 | 2009 | 1971 | 0.050 |
Why?
| | Disease Progression | 1 | 2009 | 2423 | 0.050 |
Why?
| | Animals, Genetically Modified | 3 | 2009 | 215 | 0.050 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2005 | 373 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2009 | 2586 | 0.050 |
Why?
| | Rabbits | 3 | 2009 | 752 | 0.050 |
Why?
| | NFATC Transcription Factors | 2 | 2012 | 76 | 0.050 |
Why?
| | Rats | 3 | 2018 | 5033 | 0.040 |
Why?
| | Follow-Up Studies | 1 | 2009 | 4442 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2005 | 1825 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2012 | 157 | 0.040 |
Why?
| | Protein Conformation, alpha-Helical | 1 | 2018 | 14 | 0.040 |
Why?
| | Elastic Modulus | 1 | 2018 | 118 | 0.040 |
Why?
| | Microscopy, Atomic Force | 1 | 2018 | 115 | 0.040 |
Why?
| | Adult | 3 | 2009 | 30789 | 0.040 |
Why?
| | Prognosis | 1 | 2005 | 3343 | 0.040 |
Why?
| | Structure-Activity Relationship | 1 | 2018 | 511 | 0.040 |
Why?
| | Phosphorylation | 2 | 2012 | 1571 | 0.030 |
Why?
| | Algorithms | 1 | 2004 | 1500 | 0.030 |
Why?
| | Molecular Dynamics Simulation | 1 | 2018 | 209 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2018 | 780 | 0.030 |
Why?
| | Risk Factors | 1 | 2009 | 8702 | 0.030 |
Why?
| | Heterozygote | 1 | 2016 | 252 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 2018 | 680 | 0.030 |
Why?
| | Wnt Signaling Pathway | 1 | 2016 | 148 | 0.030 |
Why?
| | DNA, Mitochondrial | 2 | 2006 | 185 | 0.030 |
Why?
| | Family | 2 | 2007 | 594 | 0.030 |
Why?
| | Collagen | 2 | 2006 | 416 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2018 | 790 | 0.030 |
Why?
| | Echocardiography | 2 | 2006 | 562 | 0.030 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 146 | 0.030 |
Why?
| | Microscopy, Electron | 1 | 2012 | 409 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2012 | 257 | 0.020 |
Why?
| | Microfilament Proteins | 1 | 2012 | 126 | 0.020 |
Why?
| | RNA, Messenger | 2 | 2012 | 2574 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2005 | 9162 | 0.020 |
Why?
| | Calcium-Binding Proteins | 1 | 2012 | 203 | 0.020 |
Why?
| | Transfection | 1 | 2012 | 866 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 388 | 0.020 |
Why?
| | Cell Size | 1 | 2009 | 81 | 0.020 |
Why?
| | Ventricular Fibrillation | 1 | 2009 | 51 | 0.020 |
Why?
| | Chromosomes, Human | 1 | 2007 | 39 | 0.020 |
Why?
| | Glutathione | 1 | 2009 | 303 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2009 | 275 | 0.020 |
Why?
| | Lod Score | 1 | 2007 | 65 | 0.020 |
Why?
| | Penetrance | 1 | 2007 | 27 | 0.020 |
Why?
| | Actins | 1 | 2009 | 383 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2007 | 297 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 2009 | 401 | 0.020 |
Why?
| | Conserved Sequence | 1 | 2007 | 219 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2007 | 352 | 0.020 |
Why?
| | Twins, Dizygotic | 1 | 2007 | 182 | 0.020 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2006 | 21 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2007 | 267 | 0.020 |
Why?
| | Malondialdehyde | 1 | 2006 | 26 | 0.020 |
Why?
| | Procollagen | 1 | 2006 | 19 | 0.020 |
Why?
| | Pedigree | 1 | 2007 | 468 | 0.020 |
Why?
| | Lipid Peroxidation | 1 | 2006 | 138 | 0.020 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2005 | 103 | 0.020 |
Why?
| | Nonmuscle Myosin Type IIB | 1 | 2004 | 7 | 0.010 |
Why?
| | Cytochrome P-450 CYP11B2 | 1 | 2004 | 1 | 0.010 |
Why?
| | Myofibrils | 1 | 2004 | 46 | 0.010 |
Why?
| | Spironolactone | 1 | 2004 | 33 | 0.010 |
Why?
| | Hypertrophy | 1 | 2004 | 110 | 0.010 |
Why?
| | Troponin T | 1 | 2004 | 49 | 0.010 |
Why?
| | Glutamine | 1 | 2004 | 91 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 930 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 147 | 0.010 |
Why?
| | Adenosine Triphosphatases | 1 | 2004 | 155 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 165 | 0.010 |
Why?
| | Cytoskeletal Proteins | 1 | 2004 | 145 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2004 | 227 | 0.010 |
Why?
| | Base Sequence | 1 | 2007 | 2114 | 0.010 |
Why?
| | Cadherins | 1 | 2004 | 175 | 0.010 |
Why?
| | beta Catenin | 1 | 2004 | 220 | 0.010 |
Why?
| | Heart | 1 | 2006 | 610 | 0.010 |
Why?
| | Ventricular Function, Left | 1 | 2005 | 475 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2004 | 332 | 0.010 |
Why?
| | Trans-Activators | 1 | 2004 | 370 | 0.010 |
Why?
| | Gene Expression | 1 | 2006 | 1436 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2005 | 1093 | 0.010 |
Why?
| | DNA | 1 | 2006 | 1356 | 0.010 |
Why?
| | Calcium | 1 | 2004 | 1103 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2004 | 1537 | 0.010 |
Why?
| | Aging | 1 | 2004 | 1632 | 0.010 |
Why?
| | Biomarkers | 1 | 2004 | 3471 | 0.010 |
Why?
| | Time Factors | 1 | 2004 | 6171 | 0.010 |
Why?
| | Adolescent | 1 | 2007 | 17922 | 0.010 |
Why?
| | Child | 1 | 2007 | 18503 | 0.000 |
Why?
|
|
Chen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|